HCoV-OC43 Spike Protein (E4U6P) Rabbit mAb #16435
- WB
Supporting Data
| REACTIVITY | Vir |
| SENSITIVITY | Transfected Only |
| MW (kDa) | 200 |
| Source/Isotype | Rabbit IgG |
Application Key:
- WB-Western Blotting
Species Cross-Reactivity Key:
- Vir-Virus
Product Information
Product Usage Information
| Application | Dilution |
|---|---|
| Western Blotting | 1:1000 |
Storage
Protocol
Specificity / Sensitivity
HCoV-OC43 Spike Protein (E4U6P) Rabbit mAb recognizes endogenous levels of total HCoV-OC43 spike protein.
Species Reactivity:
Virus
Source / Purification
Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues near the amino terminus of HCoV-OC43 spike protein.
Background
Seasonal coronaviruses are a group of viruses that cause mild to moderate upper respiratory tract infections in humans. These viruses are part of the broader coronavirus family, which includes both mild strains and more severe strains like the one responsible for the COVID-19 pandemic (SARS-CoV-2). The most common seasonal coronaviruses include HCoV-229E, HCoV-NL63, HCoV-HKU1, and HCoV-OC43. Similar to the others, HCoV-OC43 can cause mild upper respiratory tract infections. It's been known to circulate for a long time and is associated with cold-like symptoms, particularly in the winter months (1).
The HCoV-OC43 spike protein is responsible for recognizing and binding to specific receptors on the surface of host cells. These receptors are believed to be N-acetyl-9-O-acetylneuraminic acid or N-glycolylneuraminic acid. Binding of HCoV-OC43 spike protein to these receptors initiates the process of viral entry into the host cell. After binding to the receptor on the host cell surface, the HCoV-OC43 spike protein undergoes structural changes that facilitate the fusion of the viral envelope with the host cell membrane. This fusion allows the viral genetic material to enter the host cell, initiating the viral replication process (1,2).
Limited Uses
Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.
Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.